Drug Approval | July 05, 2022
Sanofi flu vaccines licensed and approved for 2022-2023 influenza season
Sanofi will begin to ship their vaccines helping to ensure more people will be immunized
Sanofi will begin to ship their vaccines helping to ensure more people will be immunized
Shanghai Public Health Clinical Center Completed the First Patient Dosing in Clinical Study of PD-L1 Antibody ASC22 in Combination with Chidamide for Functional Cure of HIV Infection
Govt committed to supporting pharma companies with industry-friendly policies
H Clinical is the leader in decentralized clinical trial support and home visits in Latin America
Companies finalize termination with an agreed-upon settlement fee of $55M to be paid to Akebia
National Institute of Biologicals should undertake the testing of more biologicals and also extend its testing expertise in helping other countries
We must try to make the health care system more accessible for people with disabilities
NADMED technology is based on proprietary extraction and the individual measurement of NAD metabolites
It is a two dose vaccine to be administered intramuscularly at 28 days apart
105 million 30 µg, 10 µg and 3 µg doses to be delivered into Q4 2022, with an option for the U.S. Government to purchase up to 195 million additional doses
Subscribe To Our Newsletter & Stay Updated
